Madhu Pandey


Madhu Pandey is Scientist II at bioassay, biosafety and impurities group, AstraZeneca. He has more than 6 years of experience at AstraZeneca focused on the development, optimization, validation, and transfer of potency assays for therapeutic proteins, monoclonal antibodies, bispecifics, Fc-fusion proteins as well as novel therapeutic modalities. He is also involved in analytical and chemistry manufacturing and controls (CMC) teams and has been a contributing author on regulatory filings from early through late clinical phases and to commercialization.

Madhu obtained his doctorate degree and post-doctoral training in Biochemistry & Molecular Biology from the University of Oklahoma Heath Science Center (HSC), Oklahoma, USA at Dr. Paul Weigel’s laboratory.